메뉴 건너뛰기




Volumn 11, Issue 1, 2009, Pages

A systematic review of cochrane anticoagulation reviews

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; CLOPIDOGREL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; WARFARIN;

EID: 58349102579     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (4)

References (113)
  • 1
    • 33645529489 scopus 로고    scopus 로고
    • Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism
    • Commentary: http://medgenmed.medscape.com/ viewarticle/557263, Art. No, CD003746. DOI: 10.1002/14651858.CD003746.pub2. Abstract available at
    • Cundiff DK, Manyemba J, Pezzullo JC. Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism. The Cochrane Database of Systematic Reviews. 2006;Issue 1. Art. No.: CD003746. DOI: 10.1002/14651858.CD003746.pub2. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003746/frame.html Commentary: http://medgenmed.medscape.com/ viewarticle/557263
    • (2006) The Cochrane Database of Systematic Reviews , Issue.1
    • Cundiff, D.K.1    Manyemba, J.2    Pezzullo, J.C.3
  • 2
    • 25144488181 scopus 로고    scopus 로고
    • Cundiff DK. Anticoagulation therapy for venous thromboembolism. MedGenMed. September 9, 2004;6. Available at http://www.medscape.com/ viewarticle/487577
    • Cundiff DK. Anticoagulation therapy for venous thromboembolism. MedGenMed. September 9, 2004;6. Available at http://www.medscape.com/ viewarticle/487577
  • 3
    • 84921431248 scopus 로고    scopus 로고
    • van Dongen CJJ, van den Belt AGM, Prins MH, Lensing AWA. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. The Cochrane Database of Systematic Reviews. 2004(4):Art. No.: CD001100.pub001102. DOI: 001110.001002/14651858.CD14001100.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/cisysrev/articles/ CD001100/frame.html Feedback letter: http://doctormanagecare.com/ vanDongen.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/ 14651858.CD001100.pub14651852&reviewGroup=HM-PVD
    • van Dongen CJJ, van den Belt AGM, Prins MH, Lensing AWA. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. The Cochrane Database of Systematic Reviews. 2004(4):Art. No.: CD001100.pub001102. DOI: 001110.001002/14651858.CD14001100.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/cisysrev/articles/ CD001100/frame.html Feedback letter: http://doctormanagecare.com/ vanDongen.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/ 14651858.CD001100.pub14651852&reviewGroup=HM-PVD
  • 4
    • 55049139942 scopus 로고    scopus 로고
    • Sandercock P, Counsell C, Stobbs SL. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. Cochrane Database of Systematic Reviews. 2005(Issue 2):Art. No.: CD000119.pub000112. DOI: 000110.001002/14651858.CD14000119.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/ clsysrev/articles/CD000119/frame.html Feedback letter http://doctormanagedcare.com/Sandercock.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=14651810.14651002/ 14651858.CD000119.pub14651852&reviewGroup=HM-STROKE
    • Sandercock P, Counsell C, Stobbs SL. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. Cochrane Database of Systematic Reviews. 2005(Issue 2):Art. No.: CD000119.pub000112. DOI: 000110.001002/14651858.CD14000119.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/ clsysrev/articles/CD000119/frame.html Feedback letter http://doctormanagedcare.com/Sandercock.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=14651810.14651002/ 14651858.CD000119.pub14651852&reviewGroup=HM-STROKE
  • 5
    • 42949084376 scopus 로고    scopus 로고
    • Akl E, Kamath G, Kim S, et al. Oral anticoagulation for prolonging survival in patients with cancer. Cochrane Database of Systematic Reviews. 2007(Issue 2):Art. No.: CD006466. DOI: 006410.001002/ 14651858.CD14006466. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD006466/frame.html Feedback letter: http://doctormanagedcare.com/ Akl.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD006466&reviewGroup=HM-GYNAECA
    • Akl E, Kamath G, Kim S, et al. Oral anticoagulation for prolonging survival in patients with cancer. Cochrane Database of Systematic Reviews. 2007(Issue 2):Art. No.: CD006466. DOI: 006410.001002/ 14651858.CD14006466. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD006466/frame.html Feedback letter: http://doctormanagedcare.com/ Akl.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD006466&reviewGroup=HM-GYNAECA
  • 6
    • 84921702902 scopus 로고    scopus 로고
    • Walker MC, Ferguson SE, Allen VM. Heparin for pregnant women with acquired or inherited thrombophilias. Cochrane Database of Systematic Reviews. 2003(Issue 2):Art. No.: CD003580. DOI: 003510.001002/ 14651858.CD003580. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003580/frame.html Feedback letter: http://doctormanagedcare.com/ Walker.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD003580&reviewGroup=HM-PREG
    • Walker MC, Ferguson SE, Allen VM. Heparin for pregnant women with acquired or inherited thrombophilias. Cochrane Database of Systematic Reviews. 2003(Issue 2):Art. No.: CD003580. DOI: 003510.001002/ 14651858.CD003580. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003580/frame.html Feedback letter: http://doctormanagedcare.com/ Walker.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD003580&reviewGroup=HM-PREG
  • 7
    • 84921537232 scopus 로고    scopus 로고
    • Wille-Jergensen P, Rasmussen M, Andersen B, Borly L. Heparins and mechanical methods for thromboprophylaxis in colorectal surgery. Cochrane Database of Systematic Reviews. 2004(Issue 1):Art. No.: CD001217 DOI: 001210.001002/14651858.CD14001217. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD001217/frame.html Feedback letter: http://doctormanagedcare.com/ WilleJorgensen.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/14651858.CD001217&reviewGroup=HM-
    • Wille-Jergensen P, Rasmussen M, Andersen B, Borly L. Heparins and mechanical methods for thromboprophylaxis in colorectal surgery. Cochrane Database of Systematic Reviews. 2004(Issue 1):Art. No.: CD001217 DOI: 001210.001002/14651858.CD14001217. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD001217/frame.html Feedback letter: http://doctormanagedcare.com/ WilleJorgensen.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/14651858.CD001217&reviewGroup=HM-
  • 8
    • 17144459755 scopus 로고    scopus 로고
    • Magee KD, Sevcik W, Moher D, Rowe BH. Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes. Cochrane Database Syst Rev. 2003(1):Art. No.: CD003462. DOI: 003410.001002/ 14651858.CD14003462.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003462/frame.html Feedback letter: http://doctormanagedcare.com/ Magee.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD003462&reviewGroup=HM-HEART
    • Magee KD, Sevcik W, Moher D, Rowe BH. Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes. Cochrane Database Syst Rev. 2003(1):Art. No.: CD003462. DOI: 003410.001002/ 14651858.CD14003462.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003462/frame.html Feedback letter: http://doctormanagedcare.com/ Magee.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD003462&reviewGroup=HM-HEART
  • 9
    • 84857189585 scopus 로고    scopus 로고
    • Biondi-Zoccai GGL, Testa L, Abbate A, Lotrionte M, Parisi Q, Agostoni P. Oral anticoagulants for the secondary prevention of coronary heart disease. Cochrane Database of Systematic Reviews. 2005(Issue 3):Art. No.: CD005350. DOI: 005310.001002/14651858.CD14005350. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD005350/frame.html Feedback letter: http://doctormanagedcare.com/Biondi.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=14651810.14651002/ 14651858.CD005350&reviewGroup=HM-VASC
    • Biondi-Zoccai GGL, Testa L, Abbate A, Lotrionte M, Parisi Q, Agostoni P. Oral anticoagulants for the secondary prevention of coronary heart disease. Cochrane Database of Systematic Reviews. 2005(Issue 3):Art. No.: CD005350. DOI: 005310.001002/14651858.CD14005350. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD005350/frame.html Feedback letter: http://doctormanagedcare.com/Biondi.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=14651810.14651002/ 14651858.CD005350&reviewGroup=HM-VASC
  • 10
    • 38649098255 scopus 로고    scopus 로고
    • Akl EA, van Doormaal FF, Barba M, et al. Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation. Cochrane Database of Systematic Reviews. 2007(Issue 3):Art. No.: CD006652. DOI: 006610.001002/14651858.CD14006652. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD006652/frame.html Feedback letter: http://doctormanagedcare.com/Akl2.htm or http://www.cochranefeedback.com/ cf/cda/feedback.do?DOI=14651810.14651002/ 14651858.CD006652&reviewGroup=HM-GYNAECA
    • Akl EA, van Doormaal FF, Barba M, et al. Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation. Cochrane Database of Systematic Reviews. 2007(Issue 3):Art. No.: CD006652. DOI: 006610.001002/14651858.CD14006652. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD006652/frame.html Feedback letter: http://doctormanagedcare.com/Akl2.htm or http://www.cochranefeedback.com/ cf/cda/feedback.do?DOI=14651810.14651002/ 14651858.CD006652&reviewGroup=HM-GYNAECA
  • 11
    • 0035226312 scopus 로고    scopus 로고
    • Cosmi B, Rubboli A, Castelvetri C, Milandri M. Ticlopidine versus oral anticoagulation for coronary stenting. Cochrane Database of Systematic Reviews. 2001(Issue 4):Art. No.: CD002133. DOI: 002110.001002/ 14651858.CD14002133. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD002133/frame.html Feedback letter: http://doctormanagedcare.com/ Cosmi.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD002133&reviewGroup=HM-VASC
    • Cosmi B, Rubboli A, Castelvetri C, Milandri M. Ticlopidine versus oral anticoagulation for coronary stenting. Cochrane Database of Systematic Reviews. 2001(Issue 4):Art. No.: CD002133. DOI: 002110.001002/ 14651858.CD14002133. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD002133/frame.html Feedback letter: http://doctormanagedcare.com/ Cosmi.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD002133&reviewGroup=HM-VASC
  • 12
    • 14544287309 scopus 로고    scopus 로고
    • Lip GYH, Felmeden D. Antiplatelet agents and anticoagulants for hypertension. Cochrane Database of Systematic Reviews. 2004(Issue 3):Art. No.: CD003186.pub003182. DOI: 003110.001002/14651858. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD003186/frame.htm Feedback letter: http://doctormanagedcare.com/Lip.htm or http://www.cochranefeedback.com/ cf/cda/feedback.do?DOI=14651810.14651002/ 14651858.CD003186.pub14651852&reviewGroup=HM-HTN
    • Lip GYH, Felmeden D. Antiplatelet agents and anticoagulants for hypertension. Cochrane Database of Systematic Reviews. 2004(Issue 3):Art. No.: CD003186.pub003182. DOI: 003110.001002/14651858. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD003186/frame.htm Feedback letter: http://doctormanagedcare.com/Lip.htm or http://www.cochranefeedback.com/ cf/cda/feedback.do?DOI=14651810.14651002/ 14651858.CD003186.pub14651852&reviewGroup=HM-HTN
  • 13
    • 80052043296 scopus 로고    scopus 로고
    • Akl EA, Barba M, Schünemann HJ, et al. Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer. Cochrane Database of Systematic Reviews. 2008(Issue 2):DOI: 10.1002/ 14651858.CD14006650.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD006650/frame.html Feedback letter: http://doctormanagedcare.com/ Akl3.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD006650&reviewGroup=HM-GYNAECA
    • Akl EA, Barba M, Schünemann HJ, et al. Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer. Cochrane Database of Systematic Reviews. 2008(Issue 2):DOI: 10.1002/ 14651858.CD14006650.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD006650/frame.html Feedback letter: http://doctormanagedcare.com/ Akl3.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD006650&reviewGroup=HM-GYNAECA
  • 14
    • 44949230213 scopus 로고    scopus 로고
    • Xie X, Li J, Yang M, Wu TX, Fan JM, Liu J. Low molecular weight heparin for diabetic kidney disease. Cochrane Database of Systematic Reviews. 2007(Issue 2):Art. No.: CD006451. DOI: 006410.001002/ 14651858.CD14006451. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD006451/frame.html Feedback letter: http://doctormanagedcare.com/Xie.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD006451&reviewGroup=HM-RENAL
    • Xie X, Li J, Yang M, Wu TX, Fan JM, Liu J. Low molecular weight heparin for diabetic kidney disease. Cochrane Database of Systematic Reviews. 2007(Issue 2):Art. No.: CD006451. DOI: 006410.001002/ 14651858.CD14006451. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD006451/frame.html Feedback letter: http://doctormanagedcare.com/Xie.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD006451&reviewGroup=HM-RENAL
  • 15
    • 84921430554 scopus 로고    scopus 로고
    • Handoll HHG, Farrar MJ, McBirnie J, et al. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures (Cochrane Review). The Cochrane Libary. 2001(Issue 2):Art. No.: CD000305. DOI: 000310.001002/14651858.CD14000305. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD000305/frame.html Feedback letter: http://doctormanagedcare.com/ Handoll.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD000305&reviewGroup=HM-MUSKINJ
    • Handoll HHG, Farrar MJ, McBirnie J, et al. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures (Cochrane Review). The Cochrane Libary. 2001(Issue 2):Art. No.: CD000305. DOI: 000310.001002/14651858.CD14000305. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD000305/frame.html Feedback letter: http://doctormanagedcare.com/ Handoll.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD000305&reviewGroup=HM-MUSKINJ
  • 16
    • 44949127292 scopus 로고    scopus 로고
    • Heparin versus placebo for acute coronary syndromes
    • http Feedback letter: http://doctormanagedcare.com/Magee14651852.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD002132&reviewGroup=HM-HEART, :Art. No, CD003462. DOI: 003410.001002/14651858.CD14003462. Abstract available at
    • Magee K, Moher D, Rowe B. Heparin versus placebo for acute coronary syndromes. Cochrane Database of Systematic Reviews. 2008(Issue 2):Art. No.: CD003462. DOI: 003410.001002/14651858.CD14003462. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD002132/frame.html http Feedback letter: http://doctormanagedcare.com/Magee14651852.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD002132&reviewGroup=HM-HEART
    • (2008) Cochrane Database of Systematic Reviews , Issue.2
    • Magee, K.1    Moher, D.2    Rowe, B.3
  • 17
    • 58349108208 scopus 로고    scopus 로고
    • Riera R, Teixeira KMC, Liu C, Walters EH. Anticoagulation therapy for pulmonary hypertension (Protocol). Cochrane Database of Systematic Reviews. 2004(Issue 1):Art. No.: CD004673. DOI: 004610.001002/ 14651858.CD14004673. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD004673/frame.html Feedback letter: http://doctormanagedcare.com/ Riera.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD004673&reviewGroup=HM-AIRWAYS
    • Riera R, Teixeira KMC, Liu C, Walters EH. Anticoagulation therapy for pulmonary hypertension (Protocol). Cochrane Database of Systematic Reviews. 2004(Issue 1):Art. No.: CD004673. DOI: 004610.001002/ 14651858.CD14004673. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD004673/frame.html Feedback letter: http://doctormanagedcare.com/ Riera.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD004673&reviewGroup=HM-AIRWAYS
  • 18
    • 58349101666 scopus 로고    scopus 로고
    • Khiani R, Sastry S, Heagerty AM, Gamble E, McCollum CN. Antithrombotic treatment for preventing recurrent stroke due to paradoxical embolism. Cochrane Database of Systematic Reviews. 2003(Issue 4):Art. No.: CD004432. DOI: 004410.001002/14651858.CD14004432. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD004432/frame.html Feedback letter: http://doctormanagedcare.com/ Khiani.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD004432&reviewGroup=HM-STROKE
    • Khiani R, Sastry S, Heagerty AM, Gamble E, McCollum CN. Antithrombotic treatment for preventing recurrent stroke due to paradoxical embolism. Cochrane Database of Systematic Reviews. 2003(Issue 4):Art. No.: CD004432. DOI: 004410.001002/14651858.CD14004432. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD004432/frame.html Feedback letter: http://doctormanagedcare.com/ Khiani.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD004432&reviewGroup=HM-STROKE
  • 19
    • 0024296209 scopus 로고
    • The value of anticoagulant therapy in deep venous thrombosis in the lower limbs in elderly, mobilized patients. A double-blind, placebo-controlled investigation with open therapeutic guidance
    • Ott P, Eldrup E, Oxholm P. The value of anticoagulant therapy in deep venous thrombosis in the lower limbs in elderly, mobilized patients. A double-blind, placebo-controlled investigation with open therapeutic guidance. Ugeskr Laeger. 1988;150:218-221.
    • (1988) Ugeskr Laeger , vol.150 , pp. 218-221
    • Ott, P.1    Eldrup, E.2    Oxholm, P.3
  • 21
    • 0028337162 scopus 로고
    • Silent pulmonary embolism in patients with deep venous thrombosis. Incidence and fate in a randomized, controlled trial of anticoagulation versus no anticoagulation
    • Nielsen HK, Husted SE, Krusell LR, Fasting H, Charles P, Hansen HH. Silent pulmonary embolism in patients with deep venous thrombosis. Incidence and fate in a randomized, controlled trial of anticoagulation versus no anticoagulation. J Intern Med. 1994;235:457-461.
    • (1994) J Intern Med , vol.235 , pp. 457-461
    • Nielsen, H.K.1    Husted, S.E.2    Krusell, L.R.3    Fasting, H.4    Charles, P.5    Hansen, H.H.6
  • 22
    • 0028267270 scopus 로고
    • Anticoagulant therapy in deep venous thrombosis. A randomized controlled study
    • Nielsen HK, Husted SE, Krusell LR, et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thromb Res. 1994;73:215-226.
    • (1994) Thromb Res , vol.73 , pp. 215-226
    • Nielsen, H.K.1    Husted, S.E.2    Krusell, L.R.3
  • 23
    • 84921537474 scopus 로고    scopus 로고
    • Anticoagulation for heart failure in sinus rhythm
    • Feedback letter: http://doctormanagedcare.com/ Lip14651852.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/14651858.CD003336&reviewGroup= HM-HEART, :Art. No, CD003336. DOI: 003310.001002/14651858.CD14003336. Abstract available at
    • Lip G, Chung I. Anticoagulation for heart failure in sinus rhythm. Cochrane Database of Systematic Reviews. 2000(Issue 2):Art. No.: CD003336. DOI: 003310.001002/14651858.CD14003336. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003336/frame.html Feedback letter: http://doctormanagedcare.com/ Lip14651852.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/14651858.CD003336&reviewGroup= HM-HEART
    • (2000) Cochrane Database of Systematic Reviews , Issue.2
    • Lip, G.1    Chung, I.2
  • 24
    • 20544453277 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. 10.1093/eurheartj/ehi204
    • Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. 10.1093/eurheartj/ehi204. Eur Heart J. 2005;26:1115-1140.
    • (2005) Eur Heart J , vol.26 , pp. 1115-1140
    • Swedberg, K.1    Cleland, J.2    Dargie, H.3
  • 25
    • 28744446343 scopus 로고    scopus 로고
    • Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. 10.1161/CIRCULATIONAHA.105.167586. Circulation. 2005;112:e154-235.
    • Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. 10.1161/CIRCULATIONAHA.105.167586. Circulation. 2005;112:e154-235.
  • 26
    • 42949129609 scopus 로고    scopus 로고
    • Shah PS, Shah N. Heparin-bonded catheters for prolonging the patency of central venous catheters in children. Cochrane Database of Systematic Reviews. 2007(Issue 4). Art. No.: CD005983. DOI:005910.001002/ 14651858.CD14005983.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD005983/frame.html Feedback letter: http://doctormanagedcare.com/ Shah.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD005983&reviewGroup=HM-PVD
    • Shah PS, Shah N. Heparin-bonded catheters for prolonging the patency of central venous catheters in children. Cochrane Database of Systematic Reviews. 2007(Issue 4). Art. No.: CD005983. DOI:005910.001002/ 14651858.CD14005983.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD005983/frame.html Feedback letter: http://doctormanagedcare.com/ Shah.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD005983&reviewGroup=HM-PVD
  • 27
    • 0031203501 scopus 로고    scopus 로고
    • Efficacy of normal saline solution versus heparin solution for maintaining patency of peripheral intravenous catheters in children
    • LeDuc K. Efficacy of normal saline solution versus heparin solution for maintaining patency of peripheral intravenous catheters in children. J Emerg Nurs. 1997;23:306-309.
    • (1997) J Emerg Nurs , vol.23 , pp. 306-309
    • LeDuc, K.1
  • 28
    • 0026262076 scopus 로고
    • A meta-analysis of effects of heparin flush and saline flush: Quality and cost implications
    • Goode CJ, Titler M, Rakel B, et al. A meta-analysis of effects of heparin flush and saline flush: quality and cost implications. Nurs Res. 1991;40:324-330.
    • (1991) Nurs Res , vol.40 , pp. 324-330
    • Goode, C.J.1    Titler, M.2    Rakel, B.3
  • 29
    • 0023754429 scopus 로고
    • Aspirin, heparin, or both to treat acute unstable angina
    • Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med. 1988;319:1105-1111.
    • (1988) N Engl J Med , vol.319 , pp. 1105-1111
    • Theroux, P.1    Ouimet, H.2    McCans, J.3
  • 30
    • 0036892858 scopus 로고    scopus 로고
    • Bertrand ME, Simoons ML, Fox KAA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. 10.1053/euhj.2002.3385. Eur Heart J. 2002;23:1809-1840.
    • Bertrand ME, Simoons ML, Fox KAA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. 10.1053/euhj.2002.3385. Eur Heart J. 2002;23:1809-1840.
  • 31
    • 0026736119 scopus 로고
    • Reactivation of unstable angina after the discontinuation of heparin
    • Theroux P, Waters D, Lam J, Juneau M, McCans J. Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med. 1992;327:141-145.
    • (1992) N Engl J Med , vol.327 , pp. 141-145
    • Theroux, P.1    Waters, D.2    Lam, J.3    Juneau, M.4    McCans, J.5
  • 32
    • 0028962819 scopus 로고
    • Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes
    • Granger CB, Miller JM, Bovill EG, et al. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation. 1995;91:1929-1935.
    • (1995) Circulation , vol.91 , pp. 1929-1935
    • Granger, C.B.1    Miller, J.M.2    Bovill, E.G.3
  • 33
    • 25744467178 scopus 로고    scopus 로고
    • Variable inhibition of coagulation activity during and after heparin infusion in patients with unstable coronary artery disease (Abstr.)
    • Oldgren J, Linder R, Egberg N, et al. Variable inhibition of coagulation activity during and after heparin infusion in patients with unstable coronary artery disease (Abstr.). Circulation. 1996;94(Suppl 1):431A.
    • (1996) Circulation , vol.94 , Issue.SUPPL. 1
    • Oldgren, J.1    Linder, R.2    Egberg, N.3
  • 34
    • 0017378490 scopus 로고
    • Heparin-induced decrease in circulating antithrombin-III
    • Marciniak E, Gockerman JP. Heparin-induced decrease in circulating antithrombin-III. Lancet. 1977;2:581-584.
    • (1977) Lancet , vol.2 , pp. 581-584
    • Marciniak, E.1    Gockerman, J.P.2
  • 35
    • 0029954939 scopus 로고    scopus 로고
    • Depletion of intravascular pools of tissue factor pathway inhibitor (TFPI) during repeated or continuous intravenous infusion of heparin in man
    • Hansen JB, Sandset PM, Huseby KR, Huseby NE, Nordøy A. Depletion of intravascular pools of tissue factor pathway inhibitor (TFPI) during repeated or continuous intravenous infusion of heparin in man. Thromb Haemost. 1996;76703-709.
    • (1996) Thromb Haemost , pp. 76703-76709
    • Hansen, J.B.1    Sandset, P.M.2    Huseby, K.R.3    Huseby, N.E.4    Nordøy, A.5
  • 36
    • 56749184590 scopus 로고    scopus 로고
    • Clinical evidence for rebound hypercoagulability after discontinuing oral anticoagulants for venous thromboembolism
    • In press
    • Cundiff DK. Clinical evidence for rebound hypercoagulability after discontinuing oral anticoagulants for venous thromboembolism. Medscape Journal of Medicine. In press.
    • Medscape Journal of Medicine
    • Cundiff, D.K.1
  • 37
    • 0034538392 scopus 로고    scopus 로고
    • New onset of venous thromboembolism among hospitalized patients at brigham and women's hospital is caused more often by prophylaxis failure than by withholding treatment
    • Goldhaber SZ, Dunn K, MacDougall RC. New onset of venous thromboembolism among hospitalized patients at brigham and women's hospital is caused more often by prophylaxis failure than by withholding treatment. Chest. 2000;118:1680-1684.
    • (2000) Chest , vol.118 , pp. 1680-1684
    • Goldhaber, S.Z.1    Dunn, K.2    MacDougall, R.C.3
  • 38
    • 38949209538 scopus 로고    scopus 로고
    • Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome
    • Ho PM, Peterson ED, Wang L, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA. 2008;299:532-539.
    • (2008) JAMA , vol.299 , pp. 532-539
    • Ho, P.M.1    Peterson, E.D.2    Wang, L.3
  • 39
    • 3843146366 scopus 로고    scopus 로고
    • Saxena R, Koudstaal PJ. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack. The Cochrane Database of Systematic Reviews. 2004(4):Art. No.: CD000187.pub000182. DOI: 000110.001002/14651858.CD14000187.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD000187/frame.htm Feedback: letter: http://doctormanagedcare.com/ Saxena2.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/ 14651858.CD000187.pub14651852&reviewGroup=HM-STROKE
    • Saxena R, Koudstaal PJ. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack. The Cochrane Database of Systematic Reviews. 2004(4):Art. No.: CD000187.pub000182. DOI: 000110.001002/14651858.CD14000187.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD000187/frame.htm Feedback: letter: http://doctormanagedcare.com/ Saxena2.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/ 14651858.CD000187.pub14651852&reviewGroup=HM-STROKE
  • 40
    • 0344861847 scopus 로고    scopus 로고
    • anticoagulation therapy for stroke prevention in atrial fibrillation: How well do randomized trials translate into clinical practice?
    • Go AS, Hylek EM, Chang Y, et al. anticoagulation therapy for stroke prevention in atrial fibrillation: How well do randomized trials translate into clinical practice? JAMA. 2003;290:2685-2692.
    • (2003) JAMA , vol.290 , pp. 2685-2692
    • Go, A.S.1    Hylek, E.M.2    Chang, Y.3
  • 41
    • 0027291892 scopus 로고
    • Bleeding complications in oral anticoagulant therapy. An analysis of risk factors
    • van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet E. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med. 1993;153:1557-1562.
    • (1993) Arch Intern Med , vol.153 , pp. 1557-1562
    • van der Meer, F.J.1    Rosendaal, F.R.2    Vandenbroucke, J.P.3    Briet, E.4
  • 42
    • 0024316072 scopus 로고
    • Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy
    • Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med. 1989;87:144-152.
    • (1989) Am J Med , vol.87 , pp. 144-152
    • Landefeld, C.S.1    Goldman, L.2
  • 43
    • 34249715284 scopus 로고    scopus 로고
    • Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation
    • Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation. 2007;115:2689-2696.
    • (2007) Circulation , vol.115 , pp. 2689-2696
    • Hylek, E.M.1    Evans-Molina, C.2    Shea, C.3    Henault, L.E.4    Regan, S.5
  • 44
    • 0027257511 scopus 로고
    • Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
    • Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med. 1993;95:315-328.
    • (1993) Am J Med , vol.95 , pp. 315-328
    • Landefeld, C.S.1    Beyth, R.J.2
  • 45
    • 84867907090 scopus 로고    scopus 로고
    • Dörffler-Melly J, Koopman MMW, Prins MH, Büller HR. Antiplatelet and anticoagulant drugs for prevention of restenosis/ reocclusion following peripheral endovascular treatment. Cochrane Database of Systematic Reviews. 2005(Issue 1):Art. No.: CD002071.pub002072. DOI: 002010.001002/14651858.CD14002071.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/ clsysrev/articles/CD002071/frame.html Feedback letter: http://doctormanagedcare.com/Dorffler.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD002071.pub14651852&reviewGroup=HM-PVD
    • Dörffler-Melly J, Koopman MMW, Prins MH, Büller HR. Antiplatelet and anticoagulant drugs for prevention of restenosis/ reocclusion following peripheral endovascular treatment. Cochrane Database of Systematic Reviews. 2005(Issue 1):Art. No.: CD002071.pub002072. DOI: 002010.001002/14651858.CD14002071.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/ clsysrev/articles/CD002071/frame.html Feedback letter: http://doctormanagedcare.com/Dorffler.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD002071.pub14651852&reviewGroup=HM-PVD
  • 46
    • 0024553851 scopus 로고
    • Effect of 18 to 24 hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty
    • Ellis SG, Roubin GS, Wilentz J, Douglas JSJ, King SBI. Effect of 18 to 24 hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J. 1989;117:777-782.
    • (1989) Am Heart J , vol.117 , pp. 777-782
    • Ellis, S.G.1    Roubin, G.S.2    Wilentz, J.3    Douglas, J.S.J.4    King, S.B.I.5
  • 47
    • 44949242528 scopus 로고    scopus 로고
    • Bani-Hani MG, Al-Khaffaf H, Titi MA, Jaradat I. Interventions for preventing venous thromboembolism following abdominal aortic surgery. Cochrane Database of Systematic Reviews. 2008(Issue 1):Art. No.: CD005509. DOI: 005510.001002/14651858.CD14005509 pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD005509/frame.html Feedback letter: http://doctormanagedcare.com/Bani.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD005509&reviewGroup=HM-PVD
    • Bani-Hani MG, Al-Khaffaf H, Titi MA, Jaradat I. Interventions for preventing venous thromboembolism following abdominal aortic surgery. Cochrane Database of Systematic Reviews. 2008(Issue 1):Art. No.: CD005509. DOI: 005510.001002/14651858.CD14005509 pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD005509/frame.html Feedback letter: http://doctormanagedcare.com/Bani.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD005509&reviewGroup=HM-PVD
  • 48
    • 34548650898 scopus 로고    scopus 로고
    • Aguilar M, Hart R, Pearce LA. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database of Systematic Reviews. 2007(Issue 3):Art. No.: CD006186. DOI: 006110.001002/14651858.CD14006186. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD006186/frame.html Feedback letter: http://doctormanagedcare.com/ Aguilar2.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651850.14651002/ 14651858.CD006186.pub14651852&reviewGroup=HM-STROKE
    • Aguilar M, Hart R, Pearce LA. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database of Systematic Reviews. 2007(Issue 3):Art. No.: CD006186. DOI: 006110.001002/14651858.CD14006186. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD006186/frame.html Feedback letter: http://doctormanagedcare.com/ Aguilar2.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651850.14651002/ 14651858.CD006186.pub14651852&reviewGroup=HM-STROKE
  • 49
    • 33744945247 scopus 로고    scopus 로고
    • Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): A randomised controlled trial
    • Connolly S, Pogue J, Hart R, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet. 2006;367:1903-1912.
    • (2006) Lancet , vol.367 , pp. 1903-1912
    • Connolly, S.1    Pogue, J.2    Hart, R.3
  • 50
    • 33846097748 scopus 로고    scopus 로고
    • The increasing incidence of anticoagulant-associated intracerebral hemorrhage
    • Flaherty ML, Kissela B, Woo D, et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007;68:116-121.
    • (2007) Neurology , vol.68 , pp. 116-121
    • Flaherty, M.L.1    Kissela, B.2    Woo, D.3
  • 51
    • 0141501507 scopus 로고    scopus 로고
    • Dörffler-Melly J, Büller HR, Koopman MM, Prins MH. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database of Systematic Reviews. 2003(Issue 3):Art. No.: CD000535. DOI: 000510.001002/14651858.CD14000535. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD000535/frame.html Feedback: http://doctormanagedcare.com/ Dorffler2.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/ 14651858.CD000535&reviewGroup=HM-PVD
    • Dörffler-Melly J, Büller HR, Koopman MM, Prins MH. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database of Systematic Reviews. 2003(Issue 3):Art. No.: CD000535. DOI: 000510.001002/14651858.CD14000535. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD000535/frame.html Feedback: http://doctormanagedcare.com/ Dorffler2.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/ 14651858.CD000535&reviewGroup=HM-PVD
  • 52
    • 33750116139 scopus 로고    scopus 로고
    • Algra A, De Schryver ELLM, van Gijn J, Kappelle LJ, Koudstaal PJ. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin. Cochrane Database of Systematic Reviews. 2006(Issue 3):Art. No.: CD001342. DOI: 001310.001002/ 14651858.CD14001342.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD001342/frame.htm Feedback letter: http://doctormanagedcare.com/ Algra.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD001342.pub14651852&reviewGroup= HM-STROKE
    • Algra A, De Schryver ELLM, van Gijn J, Kappelle LJ, Koudstaal PJ. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin. Cochrane Database of Systematic Reviews. 2006(Issue 3):Art. No.: CD001342. DOI: 001310.001002/ 14651858.CD14001342.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD001342/frame.htm Feedback letter: http://doctormanagedcare.com/ Algra.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD001342.pub14651852&reviewGroup= HM-STROKE
  • 53
    • 20144366696 scopus 로고    scopus 로고
    • Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis
    • Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-1316.
    • (2005) N Engl J Med , vol.352 , pp. 1305-1316
    • Chimowitz, M.I.1    Lynn, M.J.2    Howlett-Smith, H.3
  • 54
    • 0000884899 scopus 로고    scopus 로고
    • Aspirin versus anticoagulants in symptomatic intracranial stenosis (AVASIS)
    • Marti-Fabregas J. Aspirin versus anticoagulants in symptomatic intracranial stenosis (AVASIS). Stroke. 2001;32:1450.
    • (2001) Stroke , vol.32 , pp. 1450
    • Marti-Fabregas, J.1
  • 55
    • 33746362568 scopus 로고    scopus 로고
    • Aspirin or anticoagulants in stenosis of the middle cerebral artery: A randomized trial
    • Martí-Fàbregas J, Cocho D, Mart-́Vilalta JL, et al. Aspirin or anticoagulants in stenosis of the middle cerebral artery: A randomized trial. Cerebrovasc Dis. 2006;22:162-169.
    • (2006) Cerebrovasc Dis , vol.22 , pp. 162-169
    • Martí-Fàbregas, J.1    Cocho, D.2    Mart-́Vilalta, J.L.3
  • 56
    • 33846230041 scopus 로고    scopus 로고
    • Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): A randomised controlled trial
    • The ESPRIT Study Group
    • The ESPRIT Study Group, Algra A. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial. Lancet Neurol. 2007;6:115-124.
    • (2007) Lancet Neurol , vol.6 , pp. 115-124
    • Algra, A.1
  • 57
    • 3042704507 scopus 로고    scopus 로고
    • Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The fragmin advanced malignancy outcome study (FAMOUS)
    • Kakkar AK, Levine MN, Kadziola Z, et al. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). J Clin Oncol. 2004;22:1944-1948.
    • (2004) J Clin Oncol , vol.22 , pp. 1944-1948
    • Kakkar, A.K.1    Levine, M.N.2    Kadziola, Z.3
  • 58
    • 52949112284 scopus 로고    scopus 로고
    • A randomized trial of the low molecular weight heparin certoparin against placebo in the long-term prevention of venous thromboembolism in patients with metastatic breast cancer
    • Freund M, Kakkar AK, Haas S, et al. A randomized trial of the low molecular weight heparin certoparin against placebo in the long-term prevention of venous thromboembolism in patients with metastatic breast cancer. Blood. 2003;102:210A.
    • (2003) Blood , vol.102
    • Freund, M.1    Kakkar, A.K.2    Haas, S.3
  • 59
    • 58349106795 scopus 로고    scopus 로고
    • Antithrombotics - current market and future outlook. IMS Health. June 2005. Available at http://www1.imshealth.com/web/content/ 0,3148,64576068_63872702_70261000_74296580,00.html Accessed August 25, 2005.
    • Antithrombotics - current market and future outlook. IMS Health. June 2005. Available at http://www1.imshealth.com/web/content/ 0,3148,64576068_63872702_70261000_74296580,00.html Accessed August 25, 2005.
  • 60
    • 34447306023 scopus 로고    scopus 로고
    • Bleeding complications with warfarin use: A prevalent adverse effect resulting in regulatory action
    • Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med. 2007;167:1414-1419.
    • (2007) Arch Intern Med , vol.167 , pp. 1414-1419
    • Wysowski, D.K.1    Nourjah, P.2    Swartz, L.3
  • 61
    • 0026707776 scopus 로고
    • Hemorrhagic complications of anticoagulant treatment
    • Levine MN, Hirsh J, Landefeld S, Raskob G. Hemorrhagic complications of anticoagulant treatment. Chest. 1992;102(4 Suppl):352S-363S.
    • (1992) Chest , vol.102 , Issue.4 SUPPL.
    • Levine, M.N.1    Hirsh, J.2    Landefeld, S.3    Raskob, G.4
  • 62
    • 0027457034 scopus 로고
    • Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group
    • Fihn SD, McDonell M, Martin D, et al. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med. 1993;118:511-520.
    • (1993) Ann Intern Med , vol.118 , pp. 511-520
    • Fihn, S.D.1    McDonell, M.2    Martin, D.3
  • 63
    • 33846857559 scopus 로고    scopus 로고
    • Heart disease and stroke statistics - 2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
    • Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69-e171.
    • (2007) Circulation , vol.115
    • Rosamond, W.1    Flegal, K.2    Friday, G.3
  • 64
    • 3042784252 scopus 로고    scopus 로고
    • Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-st-segment elevation acute coronary syndromes: A systematic overview
    • Petersen JL, Mahaffey KW, Hasselblad V, et al. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-st-segment elevation acute coronary syndromes: A systematic overview. JAMA. 2004;292:89-96.
    • (2004) JAMA , vol.292 , pp. 89-96
    • Petersen, J.L.1    Mahaffey, K.W.2    Hasselblad, V.3
  • 65
    • 33747595183 scopus 로고    scopus 로고
    • The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: A systematic review of 33 randomized controlled trials
    • Leonardi MJ, McGory ML, Ko CY. The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: A systematic review of 33 randomized controlled trials. Arch Surg. 2006;141:790-799.
    • (2006) Arch Surg , vol.141 , pp. 790-799
    • Leonardi, M.J.1    McGory, M.L.2    Ko, C.Y.3
  • 66
    • 35748983238 scopus 로고    scopus 로고
    • Anderson FA Jr, Zayaruzny M, Heit JA, Fidan D, Cohen AT. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol. July 11, 2007.
    • Anderson FA Jr, Zayaruzny M, Heit JA, Fidan D, Cohen AT. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol. July 11, 2007.
  • 67
    • 35748977141 scopus 로고    scopus 로고
    • Goldhaber SZ. Venous thromboembolism risk among hospitalized patients: Magnitude of the risk is staggering. Am J Hematol. July 11, 2007.
    • Goldhaber SZ. Venous thromboembolism risk among hospitalized patients: Magnitude of the risk is staggering. Am J Hematol. July 11, 2007.
  • 68
    • 34250662223 scopus 로고    scopus 로고
    • Cundiff DK. Evidence-based Medicine and the Cochrane Collaboration on Trial. MedGenMed. June 12, 2007;9. Available at http://medgenmed.medscape.com/viewarticle/557263
    • Cundiff DK. Evidence-based Medicine and the Cochrane Collaboration on Trial. MedGenMed. June 12, 2007;9. Available at http://medgenmed.medscape.com/viewarticle/557263
  • 69
    • 84871878531 scopus 로고    scopus 로고
    • van der Heijden J, Hutten B, Büller H, Prins MH. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. The Cochrane Database of Systematic Reviews. 2001(3):Art. No.: CD002001. DOI: 002010.001002/ 14651858.CD002001. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD002001/frame.html Feedback letter: http://doctormanagedcare.com/ vanderHeijden.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/14651858.CD002001&reviewGroup= HM-PVD.
    • van der Heijden J, Hutten B, Büller H, Prins MH. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. The Cochrane Database of Systematic Reviews. 2001(3):Art. No.: CD002001. DOI: 002010.001002/ 14651858.CD002001. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD002001/frame.html Feedback letter: http://doctormanagedcare.com/ vanderHeijden.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/14651858.CD002001&reviewGroup= HM-PVD.
  • 70
    • 84907002505 scopus 로고    scopus 로고
    • Testroote M, Stigter W, Janzing H, de Visser D. Low molecular weight heparin for prevention of venous thromboembolism in patients with lower leg immobilization. Cochrane Database of Systematic Reviews. 2008(Issue 3):Art. No.: CD006681. DOI: 006610.001002/ 14651858.CD14006681.pub14651852 Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD006681/frame.html Feedback letter: http://doctormanagedcare.com/ Testroote.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/14651858.CD006681&reviewGroup= HM-PVD
    • Testroote M, Stigter W, Janzing H, de Visser D. Low molecular weight heparin for prevention of venous thromboembolism in patients with lower leg immobilization. Cochrane Database of Systematic Reviews. 2008(Issue 3):Art. No.: CD006681. DOI: 006610.001002/ 14651858.CD14006681.pub14651852 Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD006681/frame.html Feedback letter: http://doctormanagedcare.com/ Testroote.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/14651858.CD006681&reviewGroup= HM-PVD
  • 71
    • 84907174827 scopus 로고    scopus 로고
    • Hutten BA, Prins MH. Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism. The Cochrane Database of Systematic Reviews. 2006(1):Art. No.: CD001367.pub001362. DOI: 001310.001002/ 14651858.CD14001367.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD001367/frame.html Feedback letter: http://doctormanagedcare.com/ Hutten.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD001367.pub14651852&reviewGroup=HM-PVD.
    • Hutten BA, Prins MH. Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism. The Cochrane Database of Systematic Reviews. 2006(1):Art. No.: CD001367.pub001362. DOI: 001310.001002/ 14651858.CD14001367.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD001367/frame.html Feedback letter: http://doctormanagedcare.com/ Hutten.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD001367.pub14651852&reviewGroup=HM-PVD.
  • 72
    • 0037265019 scopus 로고    scopus 로고
    • vanDongen CJJ, Mac Gillavry MR, Prins MH. Once versus twice daily LMWH for the initial treatment of venous thromboembolism. The Cochrane Database of Systematic Reviews. 2005(3):Art. No.: CD003074.pub003072. DOI: 003010.001002/14651858.CD14003074.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003074/frame.html Feedback letter: http://doctormanagedcare.com/ vanDongen2.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/ 14651858.CD003074.pub14651852&reviewGroup=HM-PVD
    • vanDongen CJJ, Mac Gillavry MR, Prins MH. Once versus twice daily LMWH for the initial treatment of venous thromboembolism. The Cochrane Database of Systematic Reviews. 2005(3):Art. No.: CD003074.pub003072. DOI: 003010.001002/14651858.CD14003074.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003074/frame.html Feedback letter: http://doctormanagedcare.com/ vanDongen2.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/ 14651858.CD003074.pub14651852&reviewGroup=HM-PVD
  • 73
    • 70049090416 scopus 로고    scopus 로고
    • Alikhan R, Cohen AT. Heparin for prevention of venous thromboembolism in general medical patients (excluding stroke and MI). DOI: 10.1002/ 14651858. Cochrane Database of Systematic Reviews. 2002(3):Art. No.: CD003747 Abstract available at http://www.mrw.interscience.wiley.com/ cochrane/clsysrev/articles/CD003747/frame.html Feedback letter: http://doctormanagedcare.com/Alikhan.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=003710.001002/ 14651858.CD003747&reviewGroup=HM-PVD
    • Alikhan R, Cohen AT. Heparin for prevention of venous thromboembolism in general medical patients (excluding stroke and MI). DOI: 10.1002/ 14651858. Cochrane Database of Systematic Reviews. 2002(3):Art. No.: CD003747 Abstract available at http://www.mrw.interscience.wiley.com/ cochrane/clsysrev/articles/CD003747/frame.html Feedback letter: http://doctormanagedcare.com/Alikhan.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=003710.001002/ 14651858.CD003747&reviewGroup=HM-PVD
  • 74
    • 84962168148 scopus 로고    scopus 로고
    • Quinlan DJ, Eikelboom JW, Douketis JD. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair (Protocol). The Cochrane Database of Systematic Reviews. 2002(2):Art. No.: CD004179. DOI: 004110.001002/14651858.CD14004179. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD004179/frame.html Feedback letter: http://doctormanagedcare.com/ Quinlan.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD004179&reviewGroup=HM-PVD
    • Quinlan DJ, Eikelboom JW, Douketis JD. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair (Protocol). The Cochrane Database of Systematic Reviews. 2002(2):Art. No.: CD004179. DOI: 004110.001002/14651858.CD14004179. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD004179/frame.html Feedback letter: http://doctormanagedcare.com/ Quinlan.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD004179&reviewGroup=HM-PVD
  • 75
    • 0028284442 scopus 로고
    • A meta-analysis of methods to prevent venous thromboembolism following total hip replacement
    • Imperiale TF, Speroff T. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA. 1994;271:1780-1785.
    • (1994) JAMA , vol.271 , pp. 1780-1785
    • Imperiale, T.F.1    Speroff, T.2
  • 76
    • 58349084591 scopus 로고    scopus 로고
    • Prophylaxis of Venous Thromboembolism. Scottish Intercollegiate Guidelines Network (SIGN) Publication No. 62. October 2002. Available at http://www.sign.ac.uk/guidelines/fulltext/62/index.html Accessed November 15, 2004.
    • Prophylaxis of Venous Thromboembolism. Scottish Intercollegiate Guidelines Network (SIGN) Publication No. 62. October 2002. Available at http://www.sign.ac.uk/guidelines/fulltext/62/index.html Accessed November 15, 2004.
  • 77
    • 55049127719 scopus 로고    scopus 로고
    • Kakkos S, Geroulakos G, Caprini J, Nicolaides AN, Stansby G. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high risk patients (Protocol). Cochrane Database of Systematic Reviews. 2005(Issue 2):Art. No.: CD005258. DOI: 005210.001002/14651858.CD14005258. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD005258/frame.html Feedback letter: http://doctormanagedcare.com/Kakkos.htm or h ttp://www.cochranefeedback.com/cf/cda/feedback.do?DOI=14651810.14651002/ 14651858.CD005258&reviewGroup=HM-PVD
    • Kakkos S, Geroulakos G, Caprini J, Nicolaides AN, Stansby G. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high risk patients (Protocol). Cochrane Database of Systematic Reviews. 2005(Issue 2):Art. No.: CD005258. DOI: 005210.001002/14651858.CD14005258. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD005258/frame.html Feedback letter: http://doctormanagedcare.com/Kakkos.htm or h ttp://www.cochranefeedback.com/cf/cda/feedback.do?DOI=14651810.14651002/ 14651858.CD005258&reviewGroup=HM-PVD
  • 78
    • 18144442646 scopus 로고    scopus 로고
    • Berge E, Sandercock P. Anticoagulants versus antiplatelet agents for acute ischaemic stroke. Cochrane Database of Systematic Reviews. 2002(Issue 4):Art. No.: CD003242. DOI: 003210.001002/ 14651858.CD14003242. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003242/frame.html Feedback letter: http://doctormanagedcare.com/ Berge.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD003242&reviewGroup=HM-STROKE
    • Berge E, Sandercock P. Anticoagulants versus antiplatelet agents for acute ischaemic stroke. Cochrane Database of Systematic Reviews. 2002(Issue 4):Art. No.: CD003242. DOI: 003210.001002/ 14651858.CD14003242. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003242/frame.html Feedback letter: http://doctormanagedcare.com/ Berge.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD003242&reviewGroup=HM-STROKE
  • 79
    • 84921430730 scopus 로고    scopus 로고
    • Gubitz G, Sandercock P, Counsell C. Anticoagulants for acute ischaemic stroke. Cochrane Database of Systematic Reviews. 2004(Issue 3):Art. No.: CD000024.pub000022. DOI: 000010.001002/14651858.CD14000024.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/ clsysrev/articles/CD000024/frame.html Feedback letter: http://doctormanagedcare.com/Gubitz.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=14651810.14651002/ 14651858.CD000024.pub14651852&reviewGroup=HM-STROKE
    • Gubitz G, Sandercock P, Counsell C. Anticoagulants for acute ischaemic stroke. Cochrane Database of Systematic Reviews. 2004(Issue 3):Art. No.: CD000024.pub000022. DOI: 000010.001002/14651858.CD14000024.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/ clsysrev/articles/CD000024/frame.html Feedback letter: http://doctormanagedcare.com/Gubitz.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=14651810.14651002/ 14651858.CD000024.pub14651852&reviewGroup=HM-STROKE
  • 80
    • 70349130762 scopus 로고    scopus 로고
    • Sandercock P, Mielke O, Liu M, Counsell C. Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack. Cochrane Database of Systematic Reviews. 2003(Issue 1):Art. No.: CD000248. DOI: 000210.001002/ 14651858.CD14000248. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD000248/frame.html Feedback or letter: http://doctormanagedcare.com/ Sandercock2.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/14651858.CD000248&reviewGroup= HM-STROKE
    • Sandercock P, Mielke O, Liu M, Counsell C. Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack. Cochrane Database of Systematic Reviews. 2003(Issue 1):Art. No.: CD000248. DOI: 000210.001002/ 14651858.CD14000248. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD000248/frame.html Feedback or letter: http://doctormanagedcare.com/ Sandercock2.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/14651858.CD000248&reviewGroup= HM-STROKE
  • 81
    • 84904890493 scopus 로고    scopus 로고
    • Sandercock P, Gubitz G, Foley P, Counsell C. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database of Systematic Reviews. 2003(Issue 2):Art. No.: CD000029. DOI: 000010.001002/ 14651858.CD14000029. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD000029/frame.html Feedback or letter: http://doctormanagedcare.com/ Sandercock3.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/ 14651858.CD000029&reviewGroup=HM-STROKE.
    • Sandercock P, Gubitz G, Foley P, Counsell C. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database of Systematic Reviews. 2003(Issue 2):Art. No.: CD000029. DOI: 000010.001002/ 14651858.CD14000029. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD000029/frame.html Feedback or letter: http://doctormanagedcare.com/ Sandercock3.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/ 14651858.CD000029&reviewGroup=HM-STROKE.
  • 82
    • 0035233754 scopus 로고    scopus 로고
    • Lip GYH, Chung I. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm. Cochrane Database of Systematic Reviews. 2000(Issue 2):Art. No.: CD003333. DOI: 003310.001002/ 14651858.CD14003333. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003333/frame.html Feedback or letter: http://doctormanagedcare.com/ Lip.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD003333&reviewGroup=HM-HEART
    • Lip GYH, Chung I. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm. Cochrane Database of Systematic Reviews. 2000(Issue 2):Art. No.: CD003333. DOI: 003310.001002/ 14651858.CD14003333. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003333/frame.html Feedback or letter: http://doctormanagedcare.com/ Lip.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD003333&reviewGroup=HM-HEART
  • 83
    • 80052071929 scopus 로고    scopus 로고
    • Dörffler-Melly J, Büller HR, Koopman MM, Prins MH. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery [Review]. The Cochrane Database of Systematic Reviews. 22 April 2003; Issue 2. Art. No.: CD000536. DOI: 10.1002/ 14651858.CD000536. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD000536/frame.html Feedback or: http://doctormanagedcare.com/ Dorffler3.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=10.1002/14651858.CD000536&reviewGroup=HM-PVD
    • Dörffler-Melly J, Büller HR, Koopman MM, Prins MH. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery [Review]. The Cochrane Database of Systematic Reviews. 22 April 2003; Issue 2. Art. No.: CD000536. DOI: 10.1002/ 14651858.CD000536. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD000536/frame.html Feedback or: http://doctormanagedcare.com/ Dorffler3.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=10.1002/14651858.CD000536&reviewGroup=HM-PVD
  • 84
    • 85043389124 scopus 로고    scopus 로고
    • Cosmi B, Conti E, Coccheri S. Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication. DOI: 10.1002/14651858. Cochrane Database of Systematic Reviews. 2001(2):Art. No.: CD001999. DOI: 001910.001002/14651858.CD14001999. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/ clsysrev/articles/CD001999/frame.html Feedback or letter: http://doctormanagedcare.com/Cosmi.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=14651810.14651002/ 14651858.CD001999&reviewGroup=HM-PVD
    • Cosmi B, Conti E, Coccheri S. Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication. DOI: 10.1002/14651858. Cochrane Database of Systematic Reviews. 2001(2):Art. No.: CD001999. DOI: 001910.001002/14651858.CD14001999. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/ clsysrev/articles/CD001999/frame.html Feedback or letter: http://doctormanagedcare.com/Cosmi.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=14651810.14651002/ 14651858.CD001999&reviewGroup=HM-PVD
  • 85
    • 3843146366 scopus 로고    scopus 로고
    • Saxena R, Koudstaal PJ. Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack. Cochrane Database of Systematic Reviews. 2004(Issue 2):Art. No.: CD000185.pub000182. DOI: 000110.001002/ 14651858.CD14000185.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000185/ frame.html Feedback or letter: http://doctormanagedcare.com/Saxena.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD000185.pub14651852&reviewGroup=HM-STROKE
    • Saxena R, Koudstaal PJ. Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack. Cochrane Database of Systematic Reviews. 2004(Issue 2):Art. No.: CD000185.pub000182. DOI: 000110.001002/ 14651858.CD14000185.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000185/ frame.html Feedback or letter: http://doctormanagedcare.com/Saxena.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD000185.pub14651852&reviewGroup=HM-STROKE
  • 86
    • 85041600749 scopus 로고    scopus 로고
    • Othieno R, Abu Affan M, Okpo E. Home versus in-patient treatment for deep vein thrombosis. Cochrane Database of Systematic Reviews. 2007(Issue 3):Art. No.: CD003076. DOI: 003010.001002/ 14651858.CD14003076.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003076/frame.html Feedback or letter: http://doctormanagedcare.com/ Othieno.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD003076.pub14651852&reviewGroup=HM-PVD
    • Othieno R, Abu Affan M, Okpo E. Home versus in-patient treatment for deep vein thrombosis. Cochrane Database of Systematic Reviews. 2007(Issue 3):Art. No.: CD003076. DOI: 003010.001002/ 14651858.CD14003076.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003076/frame.html Feedback or letter: http://doctormanagedcare.com/ Othieno.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD003076.pub14651852&reviewGroup=HM-PVD
  • 87
    • 33645529489 scopus 로고    scopus 로고
    • Anticoagulants versus non steroidal anti-inflammatories or placebo for treatment of venous thromboembolism
    • Protocol
    • Cundiff DK, Manyemba J. Anticoagulants versus non steroidal anti-inflammatories or placebo for treatment of venous thromboembolism. (Protocol). Cochrane Database Syst. Review.2002, Issue 3.
    • (2002) Cochrane Database Syst. Review , Issue.3
    • Cundiff, D.K.1    Manyemba, J.2
  • 88
    • 58349092859 scopus 로고    scopus 로고
    • Cundiff DK. Reply to letters re anticoagulation therapy for venous thromboembolism. Medscape General Medicine. January 3, 2005;6. Available at http://www.medscape.com/viewarticle/496149
    • Cundiff DK. Reply to letters re anticoagulation therapy for venous
  • 89
    • 33646906184 scopus 로고    scopus 로고
    • Lundberg GD. Is the current standard of medical practice for treating venous thromboembolism simply wrong? Medscape General Medicine. September 9, 2004;6. Available at http://www.medscape.com/viewarticle/ 488717
    • Lundberg GD. Is the current standard of medical practice for treating venous thromboembolism simply wrong? Medscape General Medicine. September 9, 2004;6. Available at http://www.medscape.com/viewarticle/ 488717
  • 90
    • 84907679862 scopus 로고    scopus 로고
    • Gates S, Brocklehurst P, Davis LJ. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database of Systematic Reviews. 2002(Issue 2):Art. No.: CD001689. DOI: 001610.001002/14651858.CD14001689. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD001689/frame.html Feedback or letter: http://doctormanagedcare.com/ Gates.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD001689.pub14651852&reviewGroup=HM-PREG
    • Gates S, Brocklehurst P, Davis LJ. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database of Systematic Reviews. 2002(Issue 2):Art. No.: CD001689. DOI: 001610.001002/14651858.CD14001689. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD001689/frame.html Feedback or letter: http://doctormanagedcare.com/ Gates.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD001689.pub14651852&reviewGroup=HM-PREG
  • 92
    • 15944397421 scopus 로고    scopus 로고
    • Royal College of Obstetricians and Gynaecologists (RCOG, London UK, January 2004. Available at
    • Thromboprophylaxis during pregnancy, labour and after vaginal delivery. (Guideline; no. 37). Royal College of Obstetricians and Gynaecologists (RCOG): London (UK). January 2004. Available at http://www.rcog.org.uk/ resources/Public/pdf/Thromboprophylaxis_no037.pdf
    • Thromboprophylaxis during pregnancy, labour and after vaginal delivery. (Guideline; no. 37)
  • 93
    • 0017334710 scopus 로고
    • Prevention of Fatal Postoperative pulmonary embolism by low doses of heparin. Reappraisal of results of international multicentre trial
    • Kakkar VV, Corrigan TP, Fossard DP, Sutherland I, Thirwell J. Prevention of Fatal Postoperative pulmonary embolism by low doses of heparin. Reappraisal of results of international multicentre trial. Lancet. 1977;1:567-569.
    • (1977) Lancet , vol.1 , pp. 567-569
    • Kakkar, V.V.1    Corrigan, T.P.2    Fossard, D.P.3    Sutherland, I.4    Thirwell, J.5
  • 94
    • 85041806605 scopus 로고    scopus 로고
    • Heparin for ST-segment elevation myocardial infarction
    • Feedback or letter: http://doctormanagedcare.com/Wang.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=14651810.14651002/ 14651858.CD005349&reviewGroup=HM-VASC, :Art. No, CD005349. DOI: 005310.001002/14651858.CD14005349. Abstract available at
    • Wang Q, Magee KD. Heparin for ST-segment elevation myocardial infarction. Cochrane Database of Systematic Reviews. 2005(Issue 3):Art. No.: CD005349. DOI: 005310.001002/14651858.CD14005349. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD005349/frame.html Feedback or letter: http://doctormanagedcare.com/Wang.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=14651810.14651002/ 14651858.CD005349&reviewGroup=HM-VASC
    • (2005) Cochrane Database of Systematic Reviews , Issue.3
    • Wang, Q.1    Magee, K.D.2
  • 95
    • 84921430701 scopus 로고    scopus 로고
    • Aguilar M, Hart R. Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database of Systematic Reviews. 2005(Issue 4):Art. No.: CD001925.pub001922. DOI: 001910.001002/ 14651858.CD14001925.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD001925/frame.html Feedback or letter: http://doctormanagedcare.com/ Aguilar.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD001925.pub14651852&reviewGroup= HM-STROKE
    • Aguilar M, Hart R. Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database of Systematic Reviews. 2005(Issue 4):Art. No.: CD001925.pub001922. DOI: 001910.001002/ 14651858.CD14001925.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD001925/frame.html Feedback or letter: http://doctormanagedcare.com/ Aguilar.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD001925.pub14651852&reviewGroup= HM-STROKE
  • 96
    • 0037145826 scopus 로고    scopus 로고
    • Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: An individual patient meta-analysis
    • van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: An individual patient meta-analysis. JAMA. 2002;288:2441-2448.
    • (2002) JAMA , vol.288 , pp. 2441-2448
    • van Walraven, C.1    Hart, R.G.2    Singer, D.E.3
  • 97
    • 21844464613 scopus 로고    scopus 로고
    • Di Nisio M, Peters LW, Middeldorp S. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. Cochrane Database of Systematic Reviews. 2005(Issue 2):Art. No.: CD004734. DOI: 004710.001002/14651858.CD14004734.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD004734/frame.html Feedback or letter: http://doctormanagedcare.com/Nisio.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=14651810.14651002/ 14651858.CD004734.pub14651852&reviewGroup=HM-PREG
    • Di Nisio M, Peters LW, Middeldorp S. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. Cochrane Database of Systematic Reviews. 2005(Issue 2):Art. No.: CD004734. DOI: 004710.001002/14651858.CD14004734.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD004734/frame.html Feedback or letter: http://doctormanagedcare.com/Nisio.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=14651810.14651002/ 14651858.CD004734.pub14651852&reviewGroup=HM-PREG
  • 98
    • 58349120332 scopus 로고    scopus 로고
    • Garcia JM, Martin JLR, Subirana M, Gich I. Self management for oral anticoagulation (Protocol). Cochrane Database of Systematic Reviews. 2002(Issue 4):Art. No.: CD003839. DOI: 003810.001002/ 14651858.CD14003839. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003839/frame.html Feedback or letter: http://doctormanagedcare.com/ Garcia.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD003839&reviewGroup=HM-HEART
    • Garcia JM, Martin JLR, Subirana M, Gich I. Self management for oral anticoagulation (Protocol). Cochrane Database of Systematic Reviews. 2002(Issue 4):Art. No.: CD003839. DOI: 003810.001002/ 14651858.CD14003839. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003839/frame.html Feedback or letter: http://doctormanagedcare.com/ Garcia.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD003839&reviewGroup=HM-HEART
  • 99
    • 17044460027 scopus 로고    scopus 로고
    • Anticoagulation for cerebral sinus thrombosis
    • Feedback or letter: http://doctormanagedcare.com/ Stam.htm, :Art. No, CD002005. DOI: 002010.001002/14651858. Abstract available at
    • Stam J, de Bruijn SFTM, DeVeber G. Anticoagulation for cerebral sinus thrombosis. The Cochrane Database of Systematic Reviews. 2002(4):Art. No.: CD002005. DOI: 002010.001002/14651858. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD002005/frame.html Feedback or letter: http://doctormanagedcare.com/ Stam.htm
    • The Cochrane Database of Systematic Reviews , vol.2002 , Issue.4
    • Stam, J.1    de Bruijn, S.F.T.M.2    DeVeber, G.3
  • 100
    • 55049098674 scopus 로고    scopus 로고
    • Ramos J, Perrotta C, Badariotti G, Berenstein G. Interventions for preventing venous thromboembolism in adults undergoing knee athroscopy. Cochrane Database of Systematic Reviews. 2007(Issue 2):Art. No.: CD005259. DOI: 005210.001002/14651858.CD14005259.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD005259/frame.html Feedback or letter: http://doctormanagedcare.com/Ramos.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD005259&reviewGroup=HM-PVD
    • Ramos J, Perrotta C, Badariotti G, Berenstein G. Interventions for preventing venous thromboembolism in adults undergoing knee athroscopy. Cochrane Database of Systematic Reviews. 2007(Issue 2):Art. No.: CD005259. DOI: 005210.001002/14651858.CD14005259.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD005259/frame.html Feedback or letter: http://doctormanagedcare.com/Ramos.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD005259&reviewGroup=HM-PVD
  • 101
    • 77952466576 scopus 로고    scopus 로고
    • Salazar C, Malasquez G, Malaga G. Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparin for prevention of venous thromboembolism following total hip or knee replacement or hip repair. Cochrane Database of Systematic Reviews. 2006(Issue 2):Art. No.: CD005981. DOI: 005910.001002/14651858.CD14005981. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD005981/frame.html Feedback or letter: http://doctormanagedcare.com/ Salazar.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/14651858.CD005981%20reviewGroup=HM-PVD
    • Salazar C, Malasquez G, Malaga G. Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparin for prevention of venous thromboembolism following total hip or knee replacement or hip repair. Cochrane Database of Systematic Reviews. 2006(Issue 2):Art. No.: CD005981. DOI: 005910.001002/14651858.CD14005981. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD005981/frame.html Feedback or letter: http://doctormanagedcare.com/ Salazar.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/14651858.CD005981%20reviewGroup=HM-PVD
  • 102
    • 42949129609 scopus 로고    scopus 로고
    • Shah P, Shah N. Heparin-bonded catheters for prolonging the patency of central venous catheters in children (Protocol). Cochrane Database of Systematic Reviews. 2007(Issue 4):Art. No.: CD005983. DOI: 005910.001002/ 14651858.CD14005983.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD005983/frame.html Feedback or letter: http://doctormanagedcare.com/ Shah2.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD005983&reviewGroup=HM-PVD
    • Shah P, Shah N. Heparin-bonded catheters for prolonging the patency of central venous catheters in children (Protocol). Cochrane Database of Systematic Reviews. 2007(Issue 4):Art. No.: CD005983. DOI: 005910.001002/ 14651858.CD14005983.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD005983/frame.html Feedback or letter: http://doctormanagedcare.com/ Shah2.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD005983&reviewGroup=HM-PVD
  • 103
    • 84907394622 scopus 로고    scopus 로고
    • Shah PS, Shah N. Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children (Protocol). Cochrane Database of Systematic Reviews. 2006(Issue 2):Art. No.: CD005982. DOI: 005910.001002/14651858.CD14005982. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD005982/frame.html Feedback or letter: http://doctormanagedcare.com/ Shah2.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/14651858.CD005982&reviewGroup= HM-PVD
    • Shah PS, Shah N. Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children (Protocol). Cochrane Database of Systematic Reviews. 2006(Issue 2):Art. No.: CD005982. DOI: 005910.001002/14651858.CD14005982. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD005982/frame.html Feedback or letter: http://doctormanagedcare.com/ Shah2.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/14651858.CD005982&reviewGroup= HM-PVD
  • 104
    • 84921705962 scopus 로고    scopus 로고
    • Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database of Systematic Reviews. 2005(Issue 2):Art. No.: CD002859. DOI: 002810.001002/ 14651858.CD14002859.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD002859/frame.html Feedback or letter: http://doctormanagedcare.com/ Empson.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/ 14651858.CD002859.pub14651852&reviewGroup=HM-PREG
    • Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database of Systematic Reviews. 2005(Issue 2):Art. No.: CD002859. DOI: 002810.001002/ 14651858.CD14002859.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD002859/frame.html Feedback or letter: http://doctormanagedcare.com/ Empson.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/ 14651858.CD002859.pub14651852&reviewGroup=HM-PREG
  • 105
    • 84891640442 scopus 로고    scopus 로고
    • Little SH, Massel DR. Antiplatelet and anticoagulation for patients with prosthetic heart valves. Cochrane Database of Systematic Reviews. 2003(Issue 4):Art. No.: CD003464. DOI: 003410.001002/ 14651858.CD14003464. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003464/frame.html Feedback or letter: http://doctormanagedcare.com/ Little.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD003464&reviewGroup=HM-HEART
    • Little SH, Massel DR. Antiplatelet and anticoagulation for patients with prosthetic heart valves. Cochrane Database of Systematic Reviews. 2003(Issue 4):Art. No.: CD003464. DOI: 003410.001002/ 14651858.CD14003464. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003464/frame.html Feedback or letter: http://doctormanagedcare.com/ Little.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD003464&reviewGroup=HM-HEART
  • 106
    • 84855454243 scopus 로고    scopus 로고
    • Antithrombotic drugs for carotid artery dissection
    • Feedback or letter: http://doctormanagedcare.com/ Lyrer.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD000255&reviewGroup=HM-STROKE, :Art. No, CD000255. DOI: 000210.001002/14651858.CD14000255. Abstract available at
    • Lyrer P, Engelter S. Antithrombotic drugs for carotid artery dissection. Cochrane Database of Systematic Reviews. 2003(Issue 3):Art. No.: CD000255. DOI: 000210.001002/14651858.CD14000255. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD000255/frame.html Feedback or letter: http://doctormanagedcare.com/ Lyrer.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD000255&reviewGroup=HM-STROKE
    • (2003) Cochrane Database of Systematic Reviews , Issue.3
    • Lyrer, P.1    Engelter, S.2
  • 107
    • 44949117038 scopus 로고    scopus 로고
    • Shah P, Shah V. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database of Systematic Reviews. 2005(Issue 3):Art. No.: CD002772.pub002772. DOI: 002710.001002/ 14651858.CD14002772.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD002772/frame.html Feedback or letter: http://doctormanagedcare.com/ Shah3.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD002772.pub14651852&reviewGroup= HM-NEONATAL.
    • Shah P, Shah V. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database of Systematic Reviews. 2005(Issue 3):Art. No.: CD002772.pub002772. DOI: 002710.001002/ 14651858.CD14002772.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD002772/frame.html Feedback or letter: http://doctormanagedcare.com/ Shah3.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD002772.pub14651852&reviewGroup= HM-NEONATAL.
  • 109
  • 110
    • 33644874132 scopus 로고    scopus 로고
    • Shah P, Ng E, Sinha A. Heparin for prolonging peripheral intravenous catheter use in neonates. Cochrane Database of Systematic Reviews. 2005(Issue 4):Art. No.: CD002774. DOI: 002710.001002/ 14651858.CD14002774.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD002774/frame.html Feedback or letter: http://doctormanagedcare.com/ Shah4.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD002774.pub14651852&reviewGroup= HM-NEONATAL
    • Shah P, Ng E, Sinha A. Heparin for prolonging peripheral intravenous catheter use in neonates. Cochrane Database of Systematic Reviews. 2005(Issue 4):Art. No.: CD002774. DOI: 002710.001002/ 14651858.CD14002774.pub14651852. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD002774/frame.html Feedback or letter: http://doctormanagedcare.com/ Shah4.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD002774.pub14651852&reviewGroup= HM-NEONATAL
  • 111
    • 79953003912 scopus 로고    scopus 로고
    • Akl EA, Rohilla S, Barba M, et al. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Cochrane Database of Systematic Reviews. 2008(Issue 1):Art. No.: CD006649. DOI: 006610.001002/14651858.CD14006649. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD006649/frame.html Feedback or letter: http://doctormanagedcare.com/ Akl4.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD006649&reviewGroup=HM-GYNAECA
    • Akl EA, Rohilla S, Barba M, et al. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Cochrane Database of Systematic Reviews. 2008(Issue 1):Art. No.: CD006649. DOI: 006610.001002/14651858.CD14006649. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD006649/frame.html Feedback or letter: http://doctormanagedcare.com/ Akl4.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD006649&reviewGroup=HM-GYNAECA
  • 112
    • 58349112886 scopus 로고    scopus 로고
    • Kulshrestha S, Grieff M, Navaneethan SD. Interventions for preventing thrombosis in adults and children with nephrotic syndrome (Protocol). Cochrane Database of Systematic Reviews. 2006(Issue 2):Art. No.: CD006024. DOI: 006010.001002/14651858. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD006024/frame.html Feedback or letter: http://doctormanagedcare.com/ Kulshrestha.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/14651858.CD006024&reviewGroup= HM-RENAL
    • Kulshrestha S, Grieff M, Navaneethan SD. Interventions for preventing thrombosis in adults and children with nephrotic syndrome (Protocol). Cochrane Database of Systematic Reviews. 2006(Issue 2):Art. No.: CD006024. DOI: 006010.001002/14651858. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD006024/frame.html Feedback or letter: http://doctormanagedcare.com/ Kulshrestha.htm or http://www.cochranefeedback.com/cf/cda/ feedback.do?DOI=14651810.14651002/14651858.CD006024&reviewGroup= HM-RENAL
  • 113
    • 79953282869 scopus 로고    scopus 로고
    • Samuels JA, Strippoli GFM, Craig JC, Schena FP, Molony DA. Non-immunosuppressive treatment for IgA nephropathy (Protocol). Cochrane Database of Systematic Reviews. 2003(Issue 1):Art. No.: CD003962. DOI: 003910.001002/14651858. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003962/frame.html Feedback or letter: http://doctormanagedcare.com/ Samuels.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD003962reviewGroup=HM-RENAL
    • Samuels JA, Strippoli GFM, Craig JC, Schena FP, Molony DA. Non-immunosuppressive treatment for IgA nephropathy (Protocol). Cochrane Database of Systematic Reviews. 2003(Issue 1):Art. No.: CD003962. DOI: 003910.001002/14651858. Abstract available at http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003962/frame.html Feedback or letter: http://doctormanagedcare.com/ Samuels.htm or http://www.cochranefeedback.com/cf/cda/feedback.do?DOI= 14651810.14651002/14651858.CD003962reviewGroup=HM-RENAL


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.